Evidence map›Paper›PMID 39907789›Full record

ArticleCellular and molecular life sciences : CMLS2025

Unveiling the native architecture of adult cardiac tissue using the 3D-NaissI method.

Nicolas Pataluch, Céline Guilbeau-Frugier, Véronique Pons, Amandine Wahart, Clément Karsenty, Jean-Michel Sénard, Céline Gales

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nicolas PataluchINSERM, UMR 1297, Institut des Maladies Métaboliques et Cardiovasculaires - I2MC, Université de Toulouse, 1, avenue Jean-Poulhès , BP84225, 31432, Toulouse Cedex 4, France.
Céline Guilbeau-FrugierINSERM, UMR 1297, Institut des Maladies Métaboliques et Cardiovasculaires - I2MC, Université de Toulouse, 1, avenue Jean-Poulhès , BP84225, 31432, Toulouse Cedex 4, France.
Véronique PonsINSERM, UMR 1297, Institut des Maladies Métaboliques et Cardiovasculaires - I2MC, Université de Toulouse, 1, avenue Jean-Poulhès , BP84225, 31432, Toulouse Cedex 4, France.
Amandine WahartINSERM, UMR 1297, Institut des Maladies Métaboliques et Cardiovasculaires - I2MC, Université de Toulouse, 1, avenue Jean-Poulhès , BP84225, 31432, Toulouse Cedex 4, France.
Clément KarsentyINSERM, UMR 1297, Institut des Maladies Métaboliques et Cardiovasculaires - I2MC, Université de Toulouse, 1, avenue Jean-Poulhès , BP84225, 31432, Toulouse Cedex 4, France.
Jean-Michel SénardINSERM, UMR 1297, Institut des Maladies Métaboliques et Cardiovasculaires - I2MC, Université de Toulouse, 1, avenue Jean-Poulhès , BP84225, 31432, Toulouse Cedex 4, France.
Céline GalesINSERM, UMR 1297, Institut des Maladies Métaboliques et Cardiovasculaires - I2MC, Université de Toulouse, 1, avenue Jean-Poulhès , BP84225, 31432, Toulouse Cedex 4, France. celine.gales@inserm.fr.ORCID http://orcid.org/0000-0002-4938-1583

Funding

Agence Nationale de la Recherche ANR-18-CE06-0027-04
6 · The paper itself

Abstract

Accurately imaging adult cardiac tissue in its native state is essential for regenerative medicine and understanding heart disease. Current fluorescence methods encounter challenges with tissue fixation. Here, we introduce the 3D-NaissI (3D-Native Tissue Imaging) method, which enables rapid, cost-effective imaging of fresh cardiac tissue samples in their closest native state, and has been extended to other tissues. We validated the efficacy of 3D-NaissI in preserving cardiac tissue integrity using small biopsies under hypothermic conditions in phosphate-buffered saline, offering unparalleled resolution in confocal microscopy for imaging fluorescent small molecules and antibodies. Compared to conventional histology, 3D-NaissI preserves cardiac tissue architecture and native protein epitopes, facilitating the use of a wide range of commercial antibodies without unmasking strategies. We successfully identified specific cardiac protein expression patterns in cardiomyocytes (CMs) from rodents and humans, including for the first time ACE2 localization in the lateral membrane/T-Tubules and SGTL2 in the sarcoplasmic reticulum. These findings shed light on COVID-19-related cardiac complications and suggest novel explanations for therapeutic benefits of iSGLT2 in HFpEF patients. Additionally, we challenge the notion of "connexin-43 lateralization" in heart pathology, suggesting it may be an artifact of cardiac fixation, as 3D-NaissI clearly revealed native connexin-43 expression at the lateral membrane of healthy CMs. We also discovered previously undocumented periodic ring-like 3D structures formed by pericytes that cover the lateral surfaces of CMs. These structures, positive for laminin-2, delineate a specific spatial architecture of laminin-2 receptors on the CM surface, underscoring the pivotal role of pericytes in CM function. Lastly, 3D-NaissI facilitates the mapping of native human protein expression in fresh cardiac autopsies, offering insights into both pathological and non-pathological contexts. Therefore, 3D-NaissI provides unparalleled insights into native cardiac tissue biology and holds the promise of advancing our understanding of physiology and pathophysiology, surpassing standard histology in both resolution and accuracy.

Indexed as

HeartImaging, Three-DimensionalMyocardiumAdultAngiotensin-Converting Enzyme 2AnimalsConnexin 43COVID-19HumansMiceMicroscopy, ConfocalMyocytes, CardiacRatsSARS-CoV-2ACE2 protein, humanAngiotensin-Converting Enzyme 2Connexin 43ACE2Cardiac tissueCardiomyocytesClaudin-5Connexin-43Fluorescence confocal imagingPericytesSGTL2

Identifiers

PMID39907789
PMCPMC11799504

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.